Skip to main content

Luxexcel

HardwareEindhoven, NetherlandsFounded 2009· One of 1636 Hardware companies tracked by AMPulse

Develops a proprietary 3D printing technology for ophthalmic lenses, enabling direct printing of prescription lenses without polishing.

CEO / Founder
Fabio Esposito
Team Size
11-50
Stage
Acquired
Total Funding
$36.8M
Latest Round
Acquired
Key Investors
Innovation Industries; SET Ventures; PMV; Munich Venture Partners; Chrysalix SET; KLA; Midtop Holding; Turnstone Capital Management

Technology & Products

Key Products

VisionPlatform; VisionEngine printer; VisionMaster software; VisionClear resin

Technical position · AMPulse analysis

Ability to embed active components like sensors and holographic films during the printing process; protected by Printoptical® Technology patents.

Patent position

Luxexcel filed 0 patent families in 2022-2024 versus 16 in 2019-2021, a 100% fall against a 21% decline in tracked AM filings across the same patent offices, far steeper than the broader trend, and trails named peers LuxCreo (63) and Carbon (124) in total families filed. AMPulse analysis

Filing momentum
0 families filed 2022–2024, 16 in 2019–2021 (-100%); all tracked AM filings in the same offices -21%
Filed in
EP 44%WO 37%US 35%CN 9%
Named competitors, AM patent families
LuxCreo 63Nanofabrica 5Carbon 124

68 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.

Differentiation

Value Proposition

Enables 'One-Step-Cad-to-Optic' printing of clear prescription lenses, reducing lead times and allowing integration of electronics, waveguides, and LCDs directly into the lens.

How They Differentiate

Pioneer and only company currently capable of 3D printing ophthalmic-grade prescription lenses at volume without post-print polishing.

Market & Competition

Target Customers

Ophthalmic labs and smart eyewear manufacturers

Industry Verticals

Eyewear; Medical; Consumer Electronics; Aerospace/Defense

Competitors

LuxCreo; Nanofabrica; Carbon

Growth & Milestones

Growth Metrics

Production grew from 5,000 lenses/year in 2018 to 50,000+ total by 2022; estimated revenue $6-6.7M.

Major Milestones

2009: World's first 3D printed functional glasses; 2017: First US lab installations; 2019: Reached 5,000 lenses/year production rate; 2022: Reached 50,000 lenses total production milestone; 2022: Acquired by Meta

Notable Customers

Meta

https://www.luxexcel.com

AM patents

AM-relevant patents linked to this company.

Patents
86
Granted
8
Families
68

Leading domains: process (86), equipment (38), application (4)

Filings by year: 2021: 1 · 2020: 7 · 2019: 15 · 2017: 9 · 2016: 14 · 2015: 4

  1. METHOD FOR PRINTING AN OPTICAL COMPONENT20220134638 · US
  2. METHOD FOR PRINTING A MULTIFOCAL LENS03927534 · EP
  3. TRANSPARENT WALL, GREENHOUSE, WINDOW, FAÇADE, AND ROOF2011120681 · WO
  4. METHOD FOR PRINTING A THREE-DIMENSIONAL OPTICAL COMPONENT03698958 · EP
  5. METHOD FOR PRINTING A THREE-DIMENSIONAL OPTICAL COMPONENT03927533 · EP

Funding rounds

  • Venture Round$13.9M2018-01Source: Web
  • Venture Round$14.7M2017-01Source: Web

Why this company matters

AMPulse analysis, not a company disclosure

Luxexcel occupies a unique position in additive manufacturing as the only company capable of volume-producing ophthalmic-grade prescription lenses directly from a printer without post-print polishing. Its proprietary Printoptical Technology uses a resin jetting process that achieves optical clarity in a single step, eliminating the grinding and polishing required by conventional lens manufacturing. This allows Luxexcel to serve both traditional eyewear labs and the emerging smart eyewear market.

The company's core offering includes the VisionEngine printer, VisionMaster software, and VisionClear resin, which together enable a one-step cad-to-optic workflow. Beyond clear lenses, the technology can embed active components such as sensors, waveguides, and LCDs during printing, making it relevant for augmented reality and heads-up display applications. Luxexcel's process is based on vat photopolymerization (VPP-SLA) and is protected by its Printoptical Technology patents.

Luxexcel targets ophthalmic labs and smart eyewear manufacturers. Its most notable customer is Meta, which acquired Luxexcel in 2022 and uses the technology for Project Aria smart glasses. The company also partners with independent ophthalmic labs. Production grew from 5,000 lenses per year in 2018 to over 50,000 total by 2022, with estimated revenue of $6-7 million. Investors include Innovation Industries, SET Ventures, and PMV.

The company's strategic moat lies in its first-mover position and proprietary process for printing optical-quality lenses at volume. However, its acquisition by Meta creates an open question about long-term independence and whether the technology will remain available to third-party labs. Competitors such as LuxCreo, Nanofabrica, and Carbon have not matched Luxexcel's ability to print prescription lenses without post-processing, but they could develop competing approaches as the smart eyewear market expands.